BCG induced lower urinary tract symptoms during treatment for NMIBC—Mechanisms and management strategies

Non-muscle invasive bladder cancer (NMIBC) accounts for ~70–75% of total bladder cancer tumors and requires effective early intervention to avert progression. The cornerstone of high-risk NMIBC treatment involves trans-urethral resection of the tumor followed by intravesical Bacillus Calmette-Guerin...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Georgia Bourlotos, William Baigent, Matthew Hong, Sophie Plagakis, Luke Grundy
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2024-01-01
Schriftenreihe:	Frontiers in Neuroscience
Schlagworte:	Bacillus Calmette-Guérin (BCG) cystitis NMIBC LUTS afferent sensitization bladder cancer (BCa)
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1327053/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!